Adynovate and Inotersen Subcutaneous
Determining the interaction of Adynovate and Inotersen Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Adynovate (recombinant)
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adynovate-Inotuzumab ozogamicin
- Adynovate-Inotuzumab ozogamicin Intravenous
- Adynovate-Inova
- Adynovate-Inova 4/1 topical
- Adynovate-Inova 8/2 topical
- Adynovate-Inova ACT
- Inotersen Subcutaneous-Adynovate recombinant
- Inotersen Subcutaneous-Adzenys ER
- Inotersen Subcutaneous-Adzenys ER Oral Suspension
- Inotersen Subcutaneous-Adzenys XR-ODT
- Inotersen Subcutaneous-Aemcolo
- Inotersen Subcutaneous-Aerobid